TC BioPharm (Holdings) PLC: 2024 General Meeting Resolutions Passed

Here are the key insights extracted from the provided financial report (Form 6-K) of TC BioPharm (Holdings) PLC:

General Information:

• Reporting Company: TC BioPharm (Holdings) PLC
• Commission File Number: 001-41231
• Date of Report: December 30, 2024
• Principal Executive Office Address: Maxim 1, 2 Parklands Way, Holytown, Motherwell, ML1 4WR, Scotland, United Kingdom.
• Contact Number: +44 (0) 141 433 7557

Meeting Details:

• Type of Meeting: General Meeting of Shareholders
• Date of Meeting: December 30, 2024
• Notice Date: Resolutions were proposed in the notice dated December 13, 2024.
• Voting Results: All resolutions proposed were passed.

Resolutions Passed:

1. Resolution 1:

• Purpose: To capitalize a portion of the share premium account and distribute it as bonus shares to ordinary shareholders.
• Details: Approximately 1 bonus share for every 4 ordinary shares held.
• Votes For: 122,826,600
• Votes Against: 24,360,600
• Votes Withheld: 851,000

2. Resolution 2:

• Purpose: To allot shares or grant rights to subscribe for shares up to an aggregate nominal amount of £50,000,000 for a period of five years.
• Votes For: 107,540,400
• Votes Against: 37,379,000
• Votes Withheld: 3,118,800

3. Resolution 3:

• Purpose: To allot equity securities for cash without applying pre-emption provisions for a period of five years.
• Votes For: 113,314,200
• Votes Against: 28,657,200
• Votes Withheld: 6,066,800

Conclusion:

The general meeting resulted in significant shareholder approval for the proposed resolutions, indicating strong support for the company's strategy regarding share capitalization and equity financing. This reflects a proactive approach to enhancing shareholder value and potentially strengthening the company's financial position for future growth. The passing of these resolutions may facilitate TC BioPharm's operational and strategic objectives moving forward.